Jyoti Malhotra, MD, MPH

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Astra-Zeneca
    Topic:
    Advisory board member
    Date added:
    04/18/2025
    Date updated:
    04/18/2025
    Relationship end date:
    02/21/2025
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Bristol Meyer Squibb
    Topic:
    Consultant on NSCLC
    Date added:
    04/18/2025
    Date updated:
    04/18/2025
    Relationship end date:
    02/19/2025
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Johnson & Johnson
    Topic:
    Advisory board member
    Date added:
    04/18/2025
    Date updated:
    04/18/2025
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Daiichi Sankyo
    Topic:
    Advisory board member
    Date added:
    04/18/2025
    Date updated:
    04/18/2025
    Relationship end date:
    12/06/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Bioatla
    Topic:
    DSMC member
    Date added:
    04/18/2025
    Date updated:
    04/18/2025
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Abbvie
    Topic:
    Advisory board member
    Date added:
    04/18/2025
    Date updated:
    04/18/2025
    Relationship end date:
    09/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Regeneron
    Topic:
    Consultant on NSCLC
    Date added:
    04/18/2025
    Date updated:
    04/18/2025
    Relationship end date:
    07/16/2024
Return to 2025 San Francisco Lung Cancer Conference